loading...

EORTC Quality of Life Questionnaire - Neuroendocrine Carcinoid Module (EORTC QLQ-GINET21)

EORTC Quality of Life Group

ProQolid

Basic description

Developed in 2006

Authors

EORTC Quality of Life Group

Copyright
© QLQ-G.I.NET21 Copyright 2004 EORTC Quality of life Group. All rights reserved. Date: 20th February 2006
Objective
To assess quality of life in the gut, pancreas and liver neuroendocrine tumours
Therapeutic area
  • Digestive System Diseases
  • Neoplasms
Therapeutic indication
  • Gastrointestinal Diseases
  • Generic for Neoplasms
Gastrointestinal neuroendocrine tumours
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English
Translations
32 translation(s)
Bibliographic reference(s) of the original questionnaire

Davies AH, Larsson G, Ardill J, Friend E, Jones L, Falconi M, Bettini R, Koller M, Sezer O, Fleissner C, Taal B, Blazeby JM, Ramage JK; EORTC Quality of Life Group. Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours. Eur J Cancer. 2006 Mar;42(4):477-84 (PubMed)

Yadegarfar G, Friend L, Jones L, Plum LM, Ardill J, Taal B, Larsson G, Jeziorski K, Kwekkeboom D, Ramage JK; EORTC Quality of Life Group. Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours. Br J Cancer. 2013 Feb 5;108(2):301-10 (Full Text

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us